Table 1. Baseline characteristics.
| No.(percent) or median(range) | |
|---|---|
| Age(Y) | 55(39-67) |
| Gender | |
| Female | 60(87.0%) |
| Male | 9(13.0%) |
| Follow-up period(months) | 32.0(0.5–107) |
| APRI | 2.26(0.11-42.22) |
| MELD | 19(6-31) |
| Updated Mayo risk score | 9.53(4.34–12.44) |
| Child-pugh grade | |
| B | 26(37.7%) |
| C | 43(62.3%) |
| Preoperative liver function | |
| AST (IU/L) | 75(15–513) |
| ALT (IU/L) | 45(6–229) |
| ALP (IU/L) | 186.5(54–732) |
| GGT (IU/L) | 93.5(14–779) |
| TBIL (mg/dl) | 9.83(0.41–41.6) |
| ALB (g/dl) | 3.0(2.3–4.4) |
Notes.
- APRI
- aspartate aminotransferase-to-platelet ratio index
- MELD
- model for end-stage liver disease score
- AST
- aspartate aminotransferase
- ALT
- alanine aminotransferase
- ALP
- alkaline phosphatase
- GGT
- gamma- glutamyl transpeptidase
- TBIL
- total bilirubin
- ALB
- Albumin
Normal range: AST 13-35, ALT 7-40, ALP 35-125, GGT 7-45, TBIL 0.40-1.75, ALB4-5.5.